CHECK OUT OUR JANUARY ISSUE
 
Urology Times cover
View the latest issue online.
OnabotA use on the rise for neurogenic bladder
Rates of bladder augmentation and incontinent diversions have declined dramatically in recent years, corresponding to an increasing use of onabotulinum toxin A (Botox) for patients with neurogenic bladder, researchers reported.
Learn more
 
Self-employed? Here’s how you can save for retirement
"If you are self-employed, a solo 401(k) is an excellent option for saving for retirement," writes Jeff Witz, CFP.
Read his column
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES:
 
Prostate ablation technique yields positive results at 1 year
Two markers miss small percentage of high-grade prostate Ca
ADVERTISEMENT
Ad description here